Glucocorticoid withdrawal schemes in chronic medical disorders: A systematic review

Endocrinology and Metabolism Clinics of North America

Volumn 31, Issue 3, 2002, Pages 751-778

  Kaye, Edward M ^a   Sena Esteves, Miguel ^b  

^a GENZYME CORPORATION   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; GLUCOCORTICOID;

ADRENAL CORTEX; ASTHMA; AUTOIMMUNE DISEASE; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CROHN DISEASE; DIABETES MELLITUS; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INFLAMMATION; META ANALYSIS; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT DISEASE; REVIEW; SOCIOECONOMICS; STEROID THERAPY; SUPERINFECTION; TREATMENT FAILURE; WITHDRAWAL SYNDROME;

AUTOIMMUNE DISEASES; CHRONIC DISEASE; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0036713701     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(02)00008-7     Document Type: Review

References (44)

1. The clinical use of glucocorticoids
2. Withdrawal from glucocorticoid therapy
3. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry
4. Corticosteroids and adrenal suppression; characterizing and avoiding the problem
5. Recovery of hypothalamic-pituitary-adrenal (HPA) axis in patients with rheumatic disease receiving low-dose prednisone
6. Recovery of hypothalamo-pituitary-adrenal function after corticosteroid therapy
7. Empirical Evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
8. Perioperative glucocorticoid coverage. A reassessment 42 years after emergence of a problem
9. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone
10. Withdrawal from glucocorticoid therapy
11. Glucocorticoid therapy
12. Corticosteroids or ACTH for acute exacerbations in multiple sclerosis (Cochrane Review)
13. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
14. Side effects of 2 different dexamethasone courses for preterm infants at risk of chronic lung disease: A randomized trial
15. Steroid treatment in active Crohn's disease: A comparison between two regimens of different duration
16. Effect of a short course of prednisone in the prevention of early relapse after the emergency room treatment of acute asthma
17. A pilot study of steroid therapy after emergency department treatment of acute asthma: Is a taper needed?
18. Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children
19. Duration of systemic corticosteroids in the treatment of asthma exacerbation: A randomized study
20. A comparison of 'abruptly stopping' with 'tailing off' oral corticosteroids in acute asthma
21. High-dose, long-duration versus low-dose, short-duration corticotropin therapy for infantile spasms
22. Short versus long initial prednisone treatment in steroid-sensitive nephrotic syndrome in children
23. Tapering of corticosteroid therapy following exacerbation of asthma. A randomized, double-blind, placebo-controlled trial
24. Weaning of immunosuppression in long-term recipients of living related renal transplants: A preliminary study
25. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease
26. Double-blind trial of steroid tapering in acute asthma
27. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation
28. Systemic glucocorticoids in severe exacerbations of COPD
29. Steroid tapering in acute asthma
30. Intermittent versus long-term tapering prednisolone for initial therapy in children with idiopathic nephrotic syndrome
31. Comparison of two corticosteroid regimens for the treatment of HIV-associated idiopathic esophageal ulcer
32. Corticosteroids for acute traumatic brain injury (Cochrane Review)
33. Corticosteroid therapy for nephrotic syndrome in children (Cochrane Review)
34. Corticosteroids for acute severe asthma in hospitalised patients (Cochrane Review)
35. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy (Cochrane Review)
36. Corticosteroids for pulmonary sarcoidosis (Cochrane Review)
37. Corticosteroids for preventing relapse following acute exacerbations of asthma (Cochrane Review)
38. Corticosteroids for maintaining remission of Crohn's disease (Cochrane Review)
39. Oral corticosteroids for acute exacerbations of chronic obstructive pulmonary disease (Cochrane Review)
40. Glucocorticoid therapy for chronic obstructive pulmonary disease
41. Steroids for acute exacerbations of COPD: How long is enough?
42. Glucocorticoids in clinical practice